BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+24.41%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.16B
AUM Growth
+$2.16B
Cap. Flow
-$17.4M
Cap. Flow %
-0.81%
Top 10 Hldgs %
45.97%
Holding
84
New
9
Increased
5
Reduced
5
Closed
5

Top Buys

1
IMGN
Immunogen Inc
IMGN
$55.9M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$54.2M
3
LEGN icon
Legend Biotech
LEGN
$41.4M
4
AKRO icon
Akero Therapeutics
AKRO
$39.5M
5
ARGX icon
argenx
ARGX
$29.2M

Top Sells

1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$204M
2
SGEN
Seagen Inc. Common Stock
SGEN
$40.5M
3
BLU
BELLUS Health Inc.
BLU
$23M
4
SRPT icon
Sarepta Therapeutics
SRPT
$20M
5
MEIP icon
MEI Pharma
MEIP
$18.2M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RETA
1
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$146M 6.76% 1,430,004 +200,000 +16% +$20.4M
APLS icon
2
Apellis Pharmaceuticals
APLS
$3.48B
$144M 6.66% 1,576,000 – –
RVMD icon
3
Revolution Medicines
RVMD
$7.1B
$125M 5.81% 4,684,264 – –
TYRA icon
4
Tyra Biosciences
TYRA
$675M
$110M 5.09% 6,448,359 – –
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
$89.7M 4.16% 3,421,541 – –
ONC
6
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$89.2M 4.13% 500,000 – –
AKRO icon
7
Akero Therapeutics
AKRO
$3.74B
$78.3M 3.63% 1,676,733 +845,238 +102% +$39.5M
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$72.3M 3.35% 2,000,000 – –
SRPT icon
9
Sarepta Therapeutics
SRPT
$1.78B
$68.7M 3.19% 600,000 -175,000 -23% -$20M
CYTK icon
10
Cytokinetics
CYTK
$4.23B
$68.5M 3.18% 2,100,000 – –
IMGN
11
DELISTED
Immunogen Inc
IMGN
$55.9M 2.59% +2,961,000 New +$55.9M
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$54.2M 2.51% +250,000 New +$54.2M
IDYA icon
13
IDEAYA Biosciences
IDYA
$2.15B
$51.8M 2.4% 2,202,812 – –
SAGE
14
DELISTED
Sage Therapeutics
SAGE
$51.4M 2.39% 1,094,000 – –
NUVL icon
15
Nuvalent
NUVL
$5.52B
$51M 2.37% 1,210,192 – –
MRUS icon
16
Merus
MRUS
$4.98B
$50M 2.32% 1,900,000 – –
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$836M
$45M 2.08% 2,084,000 – –
LEGN icon
18
Legend Biotech
LEGN
$6.41B
$41.4M 1.92% +600,000 New +$41.4M
ETNB icon
19
89bio
ETNB
$1.34B
$39.8M 1.85% 2,100,000 – –
RCUS icon
20
Arcus Biosciences
RCUS
$1.13B
$32.5M 1.51% 1,602,200 +170,000 +12% +$3.45M
ISEE
21
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$32.5M 1.51% 825,000 – –
VKTX icon
22
Viking Therapeutics
VKTX
$3.04B
$32.4M 1.5% 2,000,000 – –
ARGX icon
23
argenx
ARGX
$43.6B
$29.2M 1.36% +75,000 New +$29.2M
FOLD icon
24
Amicus Therapeutics
FOLD
$2.34B
$29.2M 1.35% 2,325,000 – –
RCKT icon
25
Rocket Pharmaceuticals
RCKT
$354M
$29.1M 1.35% 1,466,051 – –
1
2 3 4